Literature DB >> 11278953

The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.

E C Thornborrow1, J J Manfredi.   

Abstract

An important regulator of the proapoptotic BAX is the tumor suppressor protein p53. Unlike the p21 gene, in which p53-dependent transcriptional activation is mediated by a response element containing two consensus p53 half-sites, it previously was reported that activation of the BAX element by p53 requires additional sequences. Here, it is demonstrated that the minimal BAX response element capable of mediating p53-dependent transcriptional activation consists of two p53 half-sites plus an adjacent 6 base pairs (5'-GGGCGT-3'). This GC-rich region constitutes a "GC box" capable both of binding members of the Sp family of transcription factors, including Sp1 in vitro, and of conferring Sp1-dependent transcriptional activation on a minimal promoter in cells. Mutations within this GC box abrogated the ability of p53 to activate transcription without affecting the affinity of p53 for its binding site, demonstrating that these 6 bases are required for p53-dependent activation. In addition, a positive correlation was observed between the ability of p53 to activate transcription in cells and the ability of Sp1 to bind this response element in vitro. Mutations that inhibited Sp1 binding also blocked the ability of p53 to activate transcription through this element. Together, these results suggest a model in which p53 requires the cooperation of Sp1 or a Sp1-like factor to mediate transcriptional activation of the human BAX promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278953     DOI: 10.1074/jbc.M011643200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1.

Authors:  Hee-Jeong Im; Mark R Pittelkow; Rajiv Kumar
Journal:  J Biol Chem       Date:  2002-02-13       Impact factor: 5.157

2.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

3.  Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.

Authors:  L L Loro; A C Johannessen; O K Vintermyr
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  Procaspase 8 and Bax are up-regulated by distinct pathways in Streptococcal pyrogenic exotoxin B-induced apoptosis.

Authors:  Chia-Wen Chang; Wan-Hua Tsai; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Pei-Jane Tsai; Ming T Lin
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

5.  DNA-binding and regulatory properties of the transcription factor and putative tumor suppressor p150(Sal2).

Authors:  Hongcang Gu; Dawei Li; Chang K Sung; Hyungshin Yim; Philip Troke; Thomas Benjamin
Journal:  Biochim Biophys Acta       Date:  2011-03-31

6.  How do transcription factors select specific binding sites in the genome?

Authors:  Yongping Pan; Chung-Jung Tsai; Buyong Ma; Ruth Nussinov
Journal:  Nat Struct Mol Biol       Date:  2009-11       Impact factor: 15.369

Review 7.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

8.  Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.

Authors:  Natalia V Oleinik; Natalia I Krupenko; David G Priest; Sergey A Krupenko
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

9.  Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.

Authors:  Vera Huang; Xin Lu; Yong Jiang; Jean Y J Wang
Journal:  BMC Biol       Date:  2009-06-26       Impact factor: 7.431

10.  Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration.

Authors:  Hiroshi Matsumoto; Yoshikuni Yakabe; Koichi Saito; Kayo Sumida; Masaru Sekijima; Koji Nakayama; Hideki Miyaura; Fumiyo Saito; Masanori Otsuka; Tomoyuki Shirai
Journal:  Cancer Inform       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.